CAJ | 학술논문

目的：观察扶正升白颗粒对恶性肿瘤化疗后所致骨髓抑制、白细胞减少的临床疗效。方法：将61例患者随机分为治疗组31例，对照组30例，治疗组予以扶正生白颗粒，观察两组的治疗前后，症状改善情况及白细胞及粒细胞变化。结果：治疗组与对照组之间无明显差异（P>0.05）。结论：扶正升白颗粒对恶性肿瘤放化疗后所致气血两虚型白细胞减少有较好的疗效，能有效升高白细胞，改善症状，减轻骨髓抑制反应，治疗恶性肿瘤放化疗致外周血白细胞减少症有显著疗效。
목적：관찰부정승백과립대악성종류화료후소치골수억제、백세포감소적림상료효。방법：장61례환자수궤분위치료조31례，대조조30례，치료조여이부정생백과립，관찰량조적치료전후，증상개선정황급백세포급립세포변화。결과：치료조여대조조지간무명현차이（P>0.05）。결론：부정승백과립대악성종류방화료후소치기혈량허형백세포감소유교호적료효，능유효승고백세포，개선증상，감경골수억제반응，치료악성종류방화료치외주혈백세포감소증유현저료효。
Objective: To observe clinical effects of Fuzheng Shengbai granule on treating blood deficiency type leukopenia following cancer. Methods:61 patients were randomly divided into two groups. The treatment group was given Fuzheng Shengbai granule. Results:In two groups, there is no obviously significant difference (P>0.05). Conclusion:Fuzheng Shengbai granule has good effects on treating blood deficiency type of leukopenia following cancer, can improve the symptom and relieve bad reaction, was better for treating blood deficiency type leukopenia reducing from cancer chemotherapy.